Microbiomics research is progressing at a rapid rate as we get a better understanding of the impact of the microbiome on our bodies via Eagle Genomics

Current and future advancements will have a profound socioeconomic impact globally. Eagle Genomics is actively engaged with global companies in their microbiomic R&D programmes. Our mixed expertise in biology, bioinformatics and knowledge management coupled with our powerful software platform has already transformed new product innovation in the microbiomic sector.

• Medical Foods & Drinks worth$9bn globally